PT  - JOURNAL ARTICLE
AU  - Feng, You-Zhen
AU  - Liu, Sidong
AU  - Cheng, Zhong-Yuan
AU  - Quiroz, Juan C.
AU  - Rezazadegan, Dana
AU  - Chen, Ping-Kang
AU  - Lin, Qi-Ting
AU  - Qian, Long
AU  - Liu, Xiao-Fang
AU  - Berkovsky, Shlomo
AU  - Coiera, Enrico
AU  - Song, Lei
AU  - Qiu, Xiao-Ming
AU  - Cai, Xiang-Ran
TI  - Severity Assessment and Progression Prediction of COVID-19 Patients based on the LesionEncoder Framework and Chest CT
AID  - 10.1101/2020.08.03.20167007
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.08.03.20167007
4099  - http://medrxiv.org/content/early/2020/08/06/2020.08.03.20167007.short
4100  - http://medrxiv.org/content/early/2020/08/06/2020.08.03.20167007.full
AB  - Automatic severity assessment and progression prediction can facilitate admission, triage, and referral of COVID-19 patients. This study aims to explore the potential use of lung lesion features in the management of COVID-19, based on the assumption that lesion features may carry important diagnostic and prognostic information for quantifying infection severity and forecasting disease progression.A novel LesionEncoder framework is proposed to detect lesions in chest CT scans and to encode lesion features for automatic severity assessment and progression prediction. The LesionEncoder framework consists of a U-Net module for detecting lesions and extracting features from individual CT slices, and a recurrent neural network (RNN) module for learning the relationship between feature vectors and collectively classifying the sequence of feature vectors.Chest CT scans of two cohorts of COVID-19 patients from two hospitals in China were used for training and testing the proposed framework. When applied to assessing severity, this framework outperformed baseline methods achieving a sensitivity of 0.818, specificity of 0.952, accuracy of 0.940, and AUC of 0.903. It also outperformed the other tested methods in disease progression prediction with a sensitivity of 0.667, specificity of 0.838, accuracy of 0.829, and AUC of 0.736. The LesionEncoder framework demonstrates a strong potential for clinical application in current COVID-19 management, particularly in automatic severity assessment of COVID-19 patients. This framework also has a potential for other lesion-focused medical image analyses.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis project was supported by Natural Science Foundation of Guangdong Province (grant no.2017A030313901); Guangzhou Science, Technology and Innovation Commission (grant no.201804010239) and Foundation for Young Talents in Higher Education of Guangdong Province (grant no.2019KQNCX005).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:IRB of the Huang Shi Central Hospital; IRB of the Xiang Yang Central HospitalAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe dataset is not publicly available due to patient privacy restrictions, but may be available from the corresponding author on reasonable request.